Alprazolam-«Grindeks»

INN: Alprazolamum

0.25 mg tablets
0.5 mg tablets
1 mg tablets

Alprazolam-«Grindeks» is used to treat moderate to severe anxiety disorders and panic attacks, and is used as an adjunctive treatment for anxiety associated with moderate depression.

PHARMACEUTICAL PARTICULARS

List of excipients
Alprazolam-«Grindeks» 0.25 mgtablet: docusate sodium, benzoate sodium, pregelatinized starch,microcrystalline cellulose, lactose, magnesium stearate, colloidalanhydrous silica.
Alprazolam-«Grindeks» 0.5 mg tablet: docusatesodium, benzoate sodium, pregelatinized starch, microcrystallinecellulose, lactose monohydrate, magnesium stearate, colloidal anhydroussilica, erythrosine aluminium lake (E 127).
Alprazolam-«Grindeks» 1 mgtablet: docusate sodium, benzoate sodium, pregelatinized starch,microcrystalline cellulose, lactose monohydrate, magnesium stearate, colloidal anhydrous silica, indigotin blue dispersed 11076 (E 132).

Incompatibilities
Not applicable.

Self- life
3 years in the original packaging.

Special precautions for storage
Do not store above 25 ° C.
Do not use after the expiry date stated on the carton!

Nature and contents of the container
10 tablets in a blister, formed from PVC film/Al foil.
3 blister (30 tablets) in a carton box.

Prescription drug (Rp).

Instruction for use and disposal
Not applicable.

MARKETING AUTHORISATION HOLDER JSC «Grindeks»; 53, Krustpils St., Riga, LV-1057, Latvia.
Phone: +371 7083205
Fax: +371 7083505

MARKETING AUTHORISATION NUMBERS: Alprazolam-«Grindeks» 0.25 mg, tablets          EST 385202;
Alprazolam-«Grindeks» 0.5 mg, tablets            EST 385102;
Alprazolam-«Grindeks» 1 mg, tablets               EST 385002

DATE OF REVISION OF THE TEXT: October, 2005.